Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy

References

• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–247.
   PubMed Web of Science ®Google Scholar
• Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009;50(Suppl 1): 122S–50S.
   PubMed Web of Science ®Google Scholar
• Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review. Eur J Radiol 1999;30:198–205.
   PubMed Web of Science ®Google Scholar
• Brix G, Griebel J, Kiessling F, Wenz F. Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast- enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging 2010;37(Suppl 1):S30–51.
   Web of Science ®Google Scholar
• Zhu A, Marcus DM, Shu HK, Shim H. Application of metabolic PET imaging in radiation oncology. Radiat Res 2012;177:436–48.
   PubMed Web of Science ®Google Scholar
• Hatt M, van Stiphout R, le Pogam A, Lammering G, Visvikis D, Lambin P. Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET. Acta Oncol 2013;52:619–26.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Yuh WT, Jajoura D, Wang JZ, Lo SS, Montebello JF, et al. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer. Cancer 2010;116:903–12.
   PubMed Web of Science ®Google Scholar
• Rusten E, Rodal J, Revheim ME, Skretting A, Bruland OS, Malinen E. Quantitative dynamic (18)FDG-PET and tracer kinetic analysis of soft tissue sarcomas. Acta Oncol Epub2012 Dec 3.
   Google Scholar
• Malinen E, Rodal J, Knudtsen IS, Sovik A, Skogmo HK. Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT. Acta Oncol 2011;50:873–82.
   PubMed Web of Science ®Google Scholar
• Roe K, Aleksandersen TB, Kristian A, Nilsen LB, Seierstad T, Qu H, et al. Preclinical dynamic 18F-FDG PET-tumor characterization and radiotherapy response assessment by kinetic compartment analysis. Acta Oncol 2010;49: 914–21.
   PubMed Web of Science ®Google Scholar
• Mullani NA, Herbst RS, O’Neil RG, Gould KL, Barron BJ, Abbruzzese JL. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: A comparison with 15O-labeled water-measured blood flow. J Nucl Med 2008;49:517–23.
   PubMed Web of Science ®Google Scholar
• Revheim ME, Kristian A, Malinen E, Bruland OS, Berner JM, Holm R, et al. Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H. Acta Oncol 2013;52: 776–82.
   PubMed Web of Science ®Google Scholar
• Cochet A, Pigeonnat S, Khoury B, Vrigneaud JM, Touzery C, Berriolo-Riedinger A, et al. Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: Comparison with angiogenesis markers and prognostic factors. J Nucl Med 2012;53:512–20.
   PubMed Web of Science ®Google Scholar
• Vriens D, de Geus-Oei LF, Heerschap A, van Laarhoven HW, Oyen WJ. Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET. Clin Colorectal Cancer 2011;10:E1–5.
   Google Scholar
• Dunnwald LK, Doot RK, Specht JM, Gralow JR, Ellis GK, Livingston RB, et al. PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: Value of static versus kinetic measures of fluorodeoxyglucose uptake. Clin Cancer Res 2011;17: 2400–9.
   PubMed Web of Science ®Google Scholar
• Fuss M. Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET). Acta Oncol 2010; 49:948–55.
   PubMed Web of Science ®Google Scholar
• Sovik A, Rodal J, Skogmo HK, Lervag C, Eilertsen K, Malinen E. Adaptive radiotherapy based on contrast enhanced cone beam CT imaging. Acta Oncol 2010; 49:972–7.
   PubMed Web of Science ®Google Scholar
• Rodal J, Sovik S, Skogmo HK, Knudtsen IS, Malinen E. Feasibility of contrast-enhanced cone-beam CT for target localization and treatment monitoring. Radiother Oncol 2010;97:521–4.
   PubMed Web of Science ®Google Scholar
• Miles KA, Williams RE. Warburg revisited: Imaging tumour blood flow and metabolism. Cancer Imaging 2008;8:81–6.
   PubMed Web of Science ®Google Scholar
• Goh V, Shastry M, Engledow A, Kozarski R, Peck J, Endozo R, et al. Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: Effect of inter- and intraobserver agreement on metabolic-vascular parameters. AJR Am J Roentgenol 2012;199:1003–9.
   PubMed Web of Science ®Google Scholar
• Eby PR, Partridge SC, White SW, Doot RK, Dunnwald LK, Schubert EK, et al. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer. Acad Radiol 2008;15:1246–54.
   PubMed Web of Science ®Google Scholar
• Igaki H, Nakagawa K, Yamashita H, Terahara A, Haga A, Shiraishi K, et al. Contrast media-assisted visualization of brain metastases by kilovoltage cone-beam CT. Acta Oncol 2009;48:314–7.
   PubMed Web of Science ®Google Scholar
• Andersen EK, Hole KH, Lund KV, Sundfor K, Kristensen GB, Lyng H, et al. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol 2013;107: 117–22.
   PubMed Web of Science ®Google Scholar
• Caruso R, Parisi A, Bonanno A, Paparo D, Quattrocchi E, Branca G, et al. Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renal, lung, thyroid and colorectal carcinomas: A brief review. Oncol Lett 2012;3:16–8.
   PubMed Web of Science ®Google Scholar